Katkin Keith's Form 4 filing
Syndax Pharmaceuticals Inc (SNDX) · filed Oct 4, 2022
- Accession no.
- 0001562180-22-007011
- Filed
- Oct 4, 2022
- Trade date
- Sep 30-Oct 4, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 12 non-derivative transactions and 6 derivative transactions. Open-market sales total $102.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Katkin KeithCIK 0001314596 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2022 | Common Stock | MOption exerciseAcquired | +2,914 | $7.88 | +$22,962.32 | 34,914 | Direct | |
| Sep 30, 2022 | Common Stock | SSaleDisposed | −2,914 | $25.07 | −$73,053.98 | 32,000 | Direct | |
| Sep 30, 2022 | Common Stock | MOption exerciseAcquired | +647 | $8.93 | +$5,777.71 | 32,647 | Direct | |
| Sep 30, 2022 | Common Stock | SSaleDisposed | −647 | $25.07 | −$16,220.29 | 32,000 | Direct | |
| Oct 3, 2022 | Common Stock | MOption exerciseAcquired | +167 | $7.88 | +$1,315.96 | 32,167 | Direct | |
| Oct 3, 2022 | Common Stock | SSaleDisposed | −167 | $25.00 | −$4,175 | 32,000 | Direct | |
| Oct 3, 2022 | Common Stock | MOption exerciseAcquired | +13 | $8.93 | +$116.09 | 32,013 | Direct | |
| Oct 3, 2022 | Common Stock | SSaleDisposed | −13 | $25.00 | −$325 | 32,000 | Direct | |
| Oct 4, 2022 | Common Stock | MOption exerciseAcquired | +137 | $7.88 | +$1,079.56 | 32,137 | Direct | |
| Oct 4, 2022 | Common Stock | SSaleDisposed | −137 | $25.00 | −$3,425 | 32,000 | Direct | |
| Oct 4, 2022 | Common Stock | MOption exerciseAcquired | +223 | $8.93 | +$1,991.39 | 32,223 | Direct | |
| Oct 4, 2022 | Common Stock | SSaleDisposed | −223 | $25.00 | −$5,575 | 32,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2022 | Common Stock | MOption exerciseDisposed | −647 | $0.00 | $0 | 0 | Direct | |
| Sep 30, 2022 | Common Stock | MOption exerciseDisposed | −2,914 | $0.00 | $0 | 0 | Direct | |
| Oct 3, 2022 | Common Stock | MOption exerciseDisposed | −13 | $0.00 | $0 | 0 | Direct | |
| Oct 3, 2022 | Common Stock | MOption exerciseDisposed | −167 | $0.00 | $0 | 0 | Direct | |
| Oct 4, 2022 | Common Stock | MOption exerciseDisposed | −223 | $0.00 | $0 | 0 | Direct | |
| Oct 4, 2022 | Common Stock | MOption exerciseDisposed | −137 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.